Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of Enhancers on the Penetration of Albuterol through Hairless Mouse Skin

  • Published : 2006.10.21
Download PDF
⟨ Previous Next ⟩

Abstract

Albuterol, a selective ${\beta}_2$-adrenergic receptor stimulant, has been introduced as a potent bronchodilator for patients with bronchial asthma, chronic obstructive bronchial disease, chronic bronchitis and pulmonary emphysema. The percutaneous permeation of albuterol sulfate was investigated in hairless mouse skin in vitro with and without pretreatment with enhancers. The enhancing effects of ethanol and various penetration enhancers such as terpenes, non-ionic surfactants, pyrrolidones, and fatty acids on the permeation of albuterol sulfate were evaluated using Franz diffusion cells. Among terpenes studied, 1,8-cineole was the most effective enhancer, which increased the permeability of albuterol sulfate approximately 33-fold compared with the control without enhancer pretrement, followed by d-limonene with enhancement ratio of 21.79. 2-Pyrrolidone-5-carboxylic acid increased the permeability of albuterol sulfate approximately 5.5-fold compared with the control. Other pyrrolidones tested showed only slight permeability enhancing effect with enhancement ratio less than 2.8. Nonionic surfactants showed moderate enhancing effects. Lauric acid increased the permeability of albuterol sulfate approximately 30-fold with decreasing the lag time from 2.85 to 0.64 hr. Oleic acid and linoleic acid showed enhancement ratio of 24.55 and 22.91, respectively. These findings would allow a more rational approach for designing formulations for the transdermal delivery of albuterol sulfate and similar drugs.

Keywords

References

  1. H.W. Kelly and S. Murphy, Beta-adrenergic agonists for acute, severe asthma, Ann. Pharmacother., 26, 81-91 (1992) https://doi.org/10.1177/106002809202600115
  2. R.C. Ahrens and G.D. Smith, Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmaco- kinetics and clinical use, Pharmacotherapy, 4, 105-121 (1984) https://doi.org/10.1002/j.1875-9114.1984.tb03330.x
  3. V.P. Shah, C.C. Peck and R.L. Williams In: K.A. Walters and J. Hadgraft, Editors, Pharmaceutical Skin Penetration Enhancement, Marcel Dekker, New York, 417-427 (1993)
  4. K.A. Walters In: J. Hadgraft and R. Guy, Editors, Penetration Enhancers and Their Use in Transdermal Therapeutic Systems, Marcel Dekker, New York, 197-246 (1989)
  5. S. Mitragotri, D. Blankschtein and R. Langer, Ultrasound-mediated transdermal protein delivery, Science, 269, 850-853 (1995) https://doi.org/10.1126/science.7638603
  6. R.R. Burnette In: J. Hadgraft and R.H. Guy, Editors, Ionto- phoresis, Marcel Dekker, New York, 247-291 (1989)
  7. M.R. Prausnitz, V.G. Bose, R. Langer and J.C. Weaver, Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery, PNAS, 90, 10504-10508 (1993) https://doi.org/10.1073/pnas.90.22.10504
  8. V.R. Sinha and M.P. Kaur, Permeation enhancers for trans- dermal drug delivery, Drug Dev. Ind. Pharm., 26, 1131-1140 (2000) https://doi.org/10.1081/DDC-100100984
  9. N. Kanikkannan, K. Kandimalla, S.S. Lamba and M. Singh, Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery, Curr. Med. Chem., 7, 593-608 (2000) https://doi.org/10.2174/0929867003374840
  10. S. Crescioli, C.A. Dal and P. Maestrelli, Controlled-release theophylline inhibits early morning airway obstruction and hyperresponsiveness in asthmatic subjects, Ann. Allergy Asthma Immunol., 77, 106-110 (1996) https://doi.org/10.1016/S1081-1206(10)63495-3
  11. V.V. Ranade, Drug delivery systems 6: transdermal drug delivery, J. Clin. Pharmacol., 31, 401-418 (1991) https://doi.org/10.1002/j.1552-4604.1991.tb01895.x
  12. R.A. Biddlecombe and S. Pleasance, Automated protein precipitation by filtration in the 96-well format, J. Chro. Biomed. Appl., 734, 257-265 (1999) https://doi.org/10.1016/S0378-4347(99)00355-2
  13. N.R. Badcock and J.A. Leach, Albuterol: transdermal absorp- tion and fingerprick blood-sample contamination from nebuli- zers, Clin. Chem., 35, 889 (1989)
  14. G. Rajeev, S. Cynthia, A. Lisa, S. James, S. Grant, F. Bahram and N. Thomas, Transdermal drug delivery systems of albuterol; in vitro and in vivo studies, J. Pharm. Sci., 81, 996-1000 (1982) https://doi.org/10.1002/jps.2600811007
  15. T. Ghafourian, P. Zandasrar, H. Hamishekar and A. Nokhodchi, The effect of penetration enhancers on drug delivery through skin: a QSAR study, J. Control. Rel., 99, 113-125 (2004) https://doi.org/10.1016/j.jconrel.2004.06.010
  16. B. Berner, G.C. Mazzenga, J.H. Otte, R.J. Steffens, R.H. Juang and C.D. Ebert, Ethanol: water mutually enhanced transdermal therapeutic system: II. Skin permeation of ethanol and nitroglycerin, J. Pharm. Sci., 78, 402-407 (1989) https://doi.org/10.1002/jps.2600780512
  17. H.R. Moghimi, A.C. Williams and B.W. Barry, Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach, J. Pharm. Pharmacol., 50, 955-964 (1998) https://doi.org/10.1111/j.2042-7158.1998.tb06909.x
  18. A. Lopez, F. Llinares, C. Cortell and M. Herraez, Comparative enhancer effect of $Span^{\circledR}$ 20 with $Tween^{\circledR}$ 20 and $Azone^{\circledR}$ on the in vitro percutaneous penetration of compounds with different lipophilities, Int. J. Pharm., 202, 133-140 (2000) https://doi.org/10.1016/S0378-5173(00)00427-0
  19. P.P. Sarpotdar and J.L. Zatz, Percutaneous absorption enhance- ment by non-ionic surfactants, Drug Dev. Ind. Pharm., 12, 1625-1647 (1986) https://doi.org/10.3109/03639048609042599
  20. K.A. Walters, A.T. Florence and P.H. Dugard, Interaction of polyoxyethylene alkyl ethers with cholesterol monolayers, J. Colloid Interface Sci., 89, 584-587 (1983) https://doi.org/10.1016/0021-9797(82)90214-4
  21. A. Casiraghi, P. Minghetti, F. Cilurzo and L. Montanari, In vitro skin permeation of soy isoflavones, comunication, Symposium Skin and Formulation, Paris, October, 55 (2003)
  22. L. Malkki and S. Tammilehto, Decomposition of salbutamol in aqueous solutions. I. The effect of pH, temperature and drug concentration, Int. J. Pharm., 63, 17-22 (1990) https://doi.org/10.1016/0378-5173(90)90095-L
  23. T.K. Ghosh, W.R. Pfister and S.I. Yum, Transdermal and Topical Drug Delivery Systems, Interpharm Press, Buffalo Grove, IL, U.S.A. (1997)
  24. A.C. Williams and B.W. Barry, Essential oils as novel human skin penetration enhancers, Int. J. Pharm., 57, R7-R9 (1989) https://doi.org/10.1016/0378-5173(89)90310-4
  25. M.E. Johnson, D. Blankschtein and R. Langer, Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism, J. Pharm. Sci., 86, 1162-1172 (1997) https://doi.org/10.1021/js960198e
  26. C.K. Lee, T. Uchida, K. Kitagawa, A. Yagi, N. Kim and S. Goto, Skin permeability of various drugs with different lipophilicity, J. Pharm. Sci., 83, 562-565 (1994) https://doi.org/10.1002/jps.2600830424
  27. Y.D. Lee, Q.Z. Quan, S.Y. Jung, J.D. Rhee and C.S. Yong, The effect of fatty acids, fatty alcohols and propylene glycol on the penetration of clenbuterol through hairless mouse skin, J. Kor. Pharm. Sci., 29, 329-335 (1999)
  28. B. Berner, G.C. Mazzenga, J.H. Otte, R.J. Steffens, R.H. Juang and C.D. Ebert, Ethanol: water mutually enhanced transdermal therapeutic system: II. Skin permeation of ethanol and nitroglycerin, J. Pharm. Sci., 78, 402-407 (1989) https://doi.org/10.1002/jps.2600780512
  29. N.A. Megrab, A.C. Williams and B.W. Barry, Oestradiol permeation across human skin, silastic and snake skin membranes: the effects of ethanol/water co-solvent systems, Int. J. Pharm., 116, 101-112 (1995) https://doi.org/10.1016/0378-5173(94)00321-U
  30. N.S. Thomas and R. Panchagnula, Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action, Eur. J. Pharm. Sci., 18, 71-79 (2003) https://doi.org/10.1016/S0928-0987(02)00242-7
  31. H.R. Moghimi, A.C. Williams and B.W. Barry, Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach, J. Pharm. Pharmacol., 50, 955-964 (1998) https://doi.org/10.1111/j.2042-7158.1998.tb06909.x
  32. A. Lopez, F. Llinares, C. Cortell and M. Herr‡ez, Comparative enhancer effect of $Span^{\circledR}$ 20 with$Tween^{\circledR}$ 20 and $Azone^{\circledR}$ on the in vitro percutaneous penetration of compounds with different lipophilities, Int. J. Pharm., 202, 133-140 (2000) https://doi.org/10.1016/S0378-5173(00)00427-0
  33. J. Borras-Blasco, A. Lopez, M.J. Morant, O. Diez-Sales and M. Herraez-Dominguez, Influence of sodium lauryl sulphate on the in vitro percutaneous absorption of compounds with different lipophilicity, Eur. J. Pharm. Sci., 5, 15-22 (1997) https://doi.org/10.1016/S0928-0987(96)00184-4
  34. J. Borras-Blasco, O. Diez-Sales, A. Lopez and M. Herraez-Dominguez, A mathematical approach to predicting the percutaneous absorption enhancing effect of sodium lauryl sulphate, Int. J. Pharm., 269, 121-129 (2004) https://doi.org/10.1016/j.ijpharm.2003.09.021
  35. N. Kanikkannan and M. Singh, Skin permeation enhancement effect and skin irritation of saturated fatty alcohols, Int. J. Pharm., 248, 219-228 (2002) https://doi.org/10.1016/S0378-5173(02)00454-4
  36. H. Okabe, Y. Obata, K. Takayama and T. Nagai, Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes, Drug. Des. Delivery, 6, 229-238 (1990)
  37. D. Monti, P. Chetoni, S. Burgalassi, M. Najarro, M. Fabrizio Saettone and E. Boldrini, Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin, Int. J. Pharm., 237, 209-214 (2002) https://doi.org/10.1016/S0378-5173(02)00032-7
  38. A.K. Jain, N.S. Thomas and R. Panchagnula, Transdermal drug delivery of imipramine hydrochloride: I. Effect of terpenes, J. Control. Rel., 79, 93-101 (2002) https://doi.org/10.1016/S0168-3659(01)00524-7
  39. B. M. Magnusson, P. Runn, K. Karlsson and L. -O. D. Koskinen, Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin releasing hormone in human epidermis, Int. J. Pharm., 157, 113-121 (1997) https://doi.org/10.1016/S0378-5173(97)00235-4
  40. T. Ghafourian, P. Zandasrar, H. Hamishekar and A. Nokhodchi, The effect of penetration enhancers on drug delivery through skin: a QSAR study, J. Control. Rel., 99, 113-125 (2004) https://doi.org/10.1016/j.jconrel.2004.06.010
  41. H.R. Moghimi, A.C. Williams and B.W. Barry, Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach, J. Pharm. Pharmacol., 50, 955-964 (1998) https://doi.org/10.1111/j.2042-7158.1998.tb06909.x
  42. Y. Ota, A. Hamada, M. Nakano and H. Saito, Evaluation of percutaneous absorption of midazolam by terpenes, Drug Metab. Pharmacokin., 18, 261-266 (2003) https://doi.org/10.2133/dmpk.18.261
  43. A. Doliwa, S. Santoyo and P. Ygartua, Effect of passive and iontophoretic skin pretreatments with terpenes on the in vitro skin transport of piroxicam, Int. J. Pharm., 229, 37-44 (2001) https://doi.org/10.1016/S0378-5173(01)00849-3
  44. A.C. Williams and B.W. Barry, The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs, Int. J. Pharm., 74, 157-168 (1991) https://doi.org/10.1016/0378-5173(91)90232-D
  45. A.C. Williams and B.W. Barry, Terpenes and the lipid-protein partitioning theory of skin penetration enhancement, Pharm. Res., 8, 17-24 (1991) https://doi.org/10.1023/A:1015813803205
  46. H. Okabe, K. Takayama, A. Ogura and T. Nagai, Effect of limonene and related compounds on the percutaneous absorption of indomethacin, Drug Des. Delivery, 4, 313-321 (1989)
  47. A.F. El-Kattan, C.S. Asbill and B.B. Michniak, The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems, Int. J. Pharm., 198, 179-189 (2000) https://doi.org/10.1016/S0378-5173(00)00330-6
  48. B.W. Barry, Lipid-Protein-Partitioning theory of skin penetration enhancement, J. Control. Rel., 15, 237-248 (1987)
  49. P.A. Cornwell and B.W. Barry, Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil, J. Pharm. Pharmacol., 46, 261-269 (1994) https://doi.org/10.1111/j.2042-7158.1994.tb03791.x
  50. A.C. Williams and B.W. Barry, Transdermal oestradiol permeation: the effects of terpene penetration enhancers. In: R.C. Scott, R.H. Guy, J. Hadgraft and H.E. Bodde(Eds), Prediction of Percutaneous Penetration: Methods, Measurements, Modelling, IBC Technical Services, London, 386-393 (1991)
  51. Y. Obata, K. Takayama, Y. Maitani, Y. Machida and T. Nagai, Effect of pretreatment of skin with cyclic monoterpenes on permeation of diclofenac in hairless rat, Biol, Pharm. Bull., 16, 312-314 (1993) https://doi.org/10.1248/bpb.16.312
  52. P.P. Sarpotdar and J.L. Zatz, Percutaneous absorption enhan- cement by non-ionic surfactants, Drug Dev. Ind. Pharm., 12, 1625-1647 (1986) https://doi.org/10.3109/03639048609042599
  53. B.Y. Zaslavsky, N.N. Ossipov, V.S. Krivitch, L.P. Baholdina and S.V. Rogozhin, Action of surface-active-substances on biological membranes: II. Hemolytic activity of non-ionic surfactants, Biochim. Biophys. Acta, 507, 1-7 (1978) https://doi.org/10.1016/0005-2736(78)90368-1
  54. K.A. Walters, P.H. Dugard and A.T. Florence, Non-ionic surfactants and gastric mucosal transport of paraquat, J. Pharm. Pharmacol., 33, 207-213 (1981) https://doi.org/10.1111/j.2042-7158.1981.tb13759.x
  55. A. Lopez, F. Llinares, C. Cortell and M. Herr‡ez, Comparative enhancer effect of $Span^{\circledR}$ 20 with$Tween^{\circledR}$ 20 and $Azone^{\circledR}$ on the in vitro percutaneous penetration of compounds with different lipophilities, Int. J. Pharm., 202, 133-140 (2000) https://doi.org/10.1016/S0378-5173(00)00427-0
  56. K.A. Walters, A.T. Florence and P.H. Dugard, Interaction of polyoxyethylene alkyl ethers with cholesterol monolayers, J. Colloid Interface Sci., 89, 584-587 (1983) https://doi.org/10.1016/0021-9797(82)90214-4
  57. P.P. Sarpotdar and J.L. Zatz, Evaluation of penetration enhancement of lidocaine by non-ionic surfactants through hairless mouse skin in vitro, J. Pharm. Sci., 75, 176-181 (1986) https://doi.org/10.1002/jps.2600750216
  58. P. Ashton, K.A. Walters, K.R. Brain and J. Hadgraft, Surfactant effects in percutaneous absoption. I. Effects on the transdermal flux of methyl nicotinate, Int J. Pharm., 87, 261 (1992) https://doi.org/10.1016/0378-5173(92)90251-V
  59. J. Shokri, A. Nokhodchi, A. Dashbolaghi, D. Hassan-Zadeh, T. Ghafourian and M. Barzegar Jalali, The effect of surfactants on the skin penetration of diazepam, Int. J. Pharm., 228, 99-107 (2001) https://doi.org/10.1016/S0378-5173(01)00805-5
  60. H. Sasaki, M. Kojima, J. Nakamura and J. Shibasaki, Enhancing effect of pyrrolidone derivatives on the transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indo- methacin, and flurbiprofen, J. Pharm, Sci., 80, 533 (1991) https://doi.org/10.1002/jps.2600800606
  61. H. Okuyama, Y. Ikeda, S. Kasai, K. Imamori, K. Takayama and T. Nagai, Influence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm, Int. J. Pharm., 186, 141-148 (1999) https://doi.org/10.1016/S0378-5173(99)00154-4
  62. S. Santoyo and P. Ygartua, Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application, European J. Pharm. Biopharm., 50, 245-250 (2000) https://doi.org/10.1016/S0939-6411(00)00097-7
  63. H.S. Gwak and I.K. Chun, Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxi- cam through hairless mouse skin, Int. J. Pharm., 236, 57-64 (2002) https://doi.org/10.1016/S0378-5173(02)00009-1
  64. M. Yamada and Y. Uda, Enhancement of percutaneous absorption of molsidomine, Chem. Pharm. Bull., 35, 3390 (1987) https://doi.org/10.1248/cpb.35.3390
  65. B.J. Aungst, N.J. Rogers and E. Shefter, Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactant, sulfoxides and amides, Int. J. Pharm., 33, 225-234 (1986) https://doi.org/10.1016/0378-5173(86)90057-8
  66. D. Lewis and J. Hadgraft, Mixed monolayers of dipalmitoyl- phospatidylcholine with $Azone^{\circledR}$ or oleic acid at the air-water interface, Int. J. Pharm., 65, 211-218 (1990) https://doi.org/10.1016/0378-5173(90)90145-T
  67. B. Ongpipattanakul, R.R. Burnette, R.O. Potts and M.L. Francoeur, Evidence that oleic acid exists in a separate phase within stratum corneum lipids, Pharm. Res., 7, 350-354 (1991)
  68. H. Tanojo, A. BosvanGeest, J.A. Bouwstra, H.E. Junginger and H.E. Bodde, In vitro human skin barrier perturbation by oleic acid: thermal analysis and freeze fracture electron microscopy studies, Thermochim. Acta, 293, 77-85 (1997) https://doi.org/10.1016/S0040-6031(97)00063-4